Nifty

:

24213.30

Sensex

:

79476.63

217.95 (0.91%)
694.39 (0.88%)

Login

Nifty
Sensex

:
:

24213.30
79476.63

217.95 (0.91%)
694.39 (0.88%)

Zota Health Care Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: Not Listed | NSE: ZOTA

Watchlist

NSE BSE

594.00

05-Jul-2024

Open
High
Low
Previous Close

610.00
610.00
587.95
604.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

27178
163.10
725.05
400.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,680.77
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,694.44
0.16%
11.68

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.42
13.66
11.21

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-2.94
10.88
-12.14

PAT CAGR (%)

10 Years
5 Years
3 Years

-2.31
4.14
-31.64

P:E (Median)

8 Years
5 Years
3 Years

-
77.84
-

P:BV (Average)

8 Years
5 Years
3 Years

-
8.75
10.41

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
98.78
109.70

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 52.20 35.25 48.09% 47.35 36.26 30.58% 42.84 34.05 25.81% 41.15 38.57 6.69%
Expenses 49.26 34.64 42.21% 46.96 35.68 31.61% 40.71 33.90 20.09% 38.05 33.35 14.09%
EBITDA 2.95 0.61 383.61% 0.39 0.57 -31.58% 2.13 0.15 1,320.00% 3.10 5.23 -40.73%
EBIDTM 5.65% 1.74% 0.81% 1.58% 4.97% 0.43% 7.53% 13.55%
Other Income 0.47 0.36 30.56% 0.69 0.24 187.50% 0.38 0.80 -52.50% 0.63 0.98 -35.71%
Interest 0.42 0.05 740.00% 0.06 0.01 500.00% 0.00 0.01 -100.00% 0.25 0.03 733.33%
Depreciation 0.68 0.55 23.64% 0.86 0.67 28.36% 0.83 0.62 33.87% 0.77 0.57 35.09%
PBT 2.32 0.37 527.03% 0.16 0.67 -76.12% 1.67 0.31 438.71% 2.71 5.61 -51.69%
Tax 0.74 0.16 362.50% -0.07 0.02 - 0.51 0.06 750.00% 0.92 1.39 -33.81%
PAT 1.58 0.21 652.38% 0.22 0.65 -66.15% 1.16 0.25 364.00% 1.79 4.22 -57.58%
PATM 3.03% 0.60% 0.47% 1.80% 2.70% 0.74% 4.34% 10.95%
EPS 0.58 0.08 625.00% 0.08 0.24 -66.67% 0.42 0.09 366.67% 0.65 1.54 -57.79%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 56.30 38.65 45.67% 49.64 36.85 34.71% 46.93 34.97 34.20% 45.27 38.95 16.23%
Expenses 57.56 37.37 54.03% 51.12 35.82 42.71% 43.60 34.94 24.79% 40.85 34.12 19.72%
EBITDA -1.26 1.28 - -1.48 1.03 - 3.33 0.03 11,000.00% 4.43 4.84 -8.47%
EBIDTM -2.24% 3.31% -2.99% 2.80% 7.10% 0.08% 9.78% 12.41%
Other Income 0.02 0.15 -86.67% 0.46 0.03 1,433.33% 0.15 0.62 -75.81% 0.40 0.84 -52.38%
Interest 2.90 0.83 249.40% 1.68 0.81 107.41% 1.14 0.71 60.56% 1.14 0.66 72.73%
Depreciation 8.02 3.41 135.19% 6.80 3.88 75.26% 5.08 3.30 53.94% 4.80 2.87 67.25%
PBT -12.16 -2.81 - -9.51 -3.09 - -2.73 -3.37 - -1.11 2.15 -
Tax 0.56 0.03 1,766.67% -2.59 -0.46 - 0.21 -0.14 - 0.54 1.24 -56.45%
PAT -12.72 -2.84 - -6.92 -2.64 - -2.94 -3.23 - -1.65 0.91 -
PATM -22.60% -7.35% -13.94% -7.15% -6.26% -9.22% -3.65% 2.33%
EPS -4.80 -1.13 - -2.68 -1.05 - -1.14 -1.28 - -0.64 0.36 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 183.54 166.52 138.32 131.51 106.82 95.11 85.63 77.84 71.58 64.73 56.46 Net Sales Growth 27.34% 20.39% 5.18% 23.11% 12.31% 11.07% 10.01% 8.75% 10.58% 14.65% Cost Of Goods Sold 112.54 104.45 88.25 87.54 73.34 66.30 57.01 51.04 45.15 42.11 36.80 Gross Profit 71.00 62.07 50.07 43.97 33.47 28.81 28.62 26.81 26.43 22.62 19.66 GP Margin 38.68% 37.27% 36.20% 33.43% 31.33% 30.29% 33.42% 34.44% 36.92% 34.95% 34.82% Total Expenditure 174.98 160.21 130.98 116.52 106.19 90.58 77.88 67.02 61.54 55.17 47.96 Power & Fuel Cost - 3.47 4.04 0.90 0.76 0.68 0.61 0.44 0.33 0.37 0.30 % Of Sales - 2.08% 2.92% 0.68% 0.71% 0.71% 0.71% 0.57% 0.46% 0.57% 0.53% Employee Cost - 18.76 10.68 9.10 8.56 9.59 8.02 6.28 5.79 4.79 3.93 % Of Sales - 11.27% 7.72% 6.92% 8.01% 10.08% 9.37% 8.07% 8.09% 7.40% 6.96% Manufacturing Exp. - 2.63 1.70 2.35 1.96 1.79 1.83 2.02 2.24 1.90 1.65 % Of Sales - 1.58% 1.23% 1.79% 1.83% 1.88% 2.14% 2.60% 3.13% 2.94% 2.92% General & Admin Exp. - 6.36 4.87 7.55 6.78 6.07 5.54 3.47 3.00 2.46 2.38 % Of Sales - 3.82% 3.52% 5.74% 6.35% 6.38% 6.47% 4.46% 4.19% 3.80% 4.22% Selling & Distn. Exp. - 24.42 21.27 9.01 14.62 5.88 4.46 3.46 4.82 3.45 2.79 % Of Sales - 14.66% 15.38% 6.85% 13.69% 6.18% 5.21% 4.45% 6.73% 5.33% 4.94% Miscellaneous Exp. - 0.12 0.16 0.07 0.16 0.28 0.41 0.32 0.21 0.09 2.79 % Of Sales - 0.07% 0.12% 0.05% 0.15% 0.29% 0.48% 0.41% 0.29% 0.14% 0.19% EBITDA 8.57 6.31 7.34 14.99 0.63 4.53 7.75 10.82 10.04 9.56 8.50 EBITDA Margin 4.67% 3.79% 5.31% 11.40% 0.59% 4.76% 9.05% 13.90% 14.03% 14.77% 15.05% Other Income 2.17 1.96 3.23 2.00 1.30 1.52 1.54 1.59 0.06 0.08 0.01 Interest 0.73 0.36 0.06 0.07 0.11 0.07 0.04 0.12 0.68 0.68 0.66 Depreciation 3.14 3.01 2.42 2.73 3.17 2.10 1.39 0.94 1.05 1.23 1.51 PBT 6.86 4.91 8.09 14.19 -1.34 3.88 7.86 11.36 8.36 7.72 6.34 Tax 2.10 1.53 2.03 3.61 -0.15 1.12 2.31 4.07 2.82 2.61 2.08 Tax Rate 30.61% 31.16% 23.52% 25.44% 48.39% 28.87% 29.39% 35.89% 33.73% 33.81% 32.81% PAT 4.75 3.38 6.59 10.58 -0.16 2.76 5.55 7.27 5.54 5.11 4.27 PAT before Minority Interest 4.75 3.38 6.59 10.58 -0.16 2.76 5.55 7.27 5.54 5.11 4.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.59% 2.03% 4.76% 8.05% -0.15% 2.90% 6.48% 9.34% 7.74% 7.89% 7.56% PAT Growth -10.88% -48.71% -37.71% - - -50.27% -23.66% 31.23% 8.41% 19.67% EPS 1.73 1.23 2.41 3.86 -0.06 1.01 2.03 2.65 2.02 1.86 1.56

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 198.14 180.43 139.91 131.17 106.77 95.11 85.63 Net Sales Growth 32.61% 28.96% 6.66% 22.85% 12.26% 11.07% Cost Of Goods Sold 99.35 96.70 83.27 86.62 73.28 66.30 57.01 Gross Profit 98.79 83.72 56.64 44.55 33.48 28.81 28.62 GP Margin 49.86% 46.40% 40.48% 33.96% 31.36% 30.29% 33.42% Total Expenditure 193.13 172.87 133.25 116.73 106.19 90.60 77.89 Power & Fuel Cost - 2.31 1.35 0.94 0.77 0.68 0.61 % Of Sales - 1.28% 0.96% 0.72% 0.72% 0.71% 0.71% Employee Cost - 29.24 12.15 9.48 8.56 9.59 8.02 % Of Sales - 16.21% 8.68% 7.23% 8.02% 10.08% 9.37% Manufacturing Exp. - 2.69 1.72 2.35 1.96 1.79 1.83 % Of Sales - 1.49% 1.23% 1.79% 1.84% 1.88% 2.14% General & Admin Exp. - 11.74 8.21 7.81 6.83 6.24 5.54 % Of Sales - 6.51% 5.87% 5.95% 6.40% 6.56% 6.47% Selling & Distn. Exp. - 30.08 26.38 9.47 14.62 5.83 4.46 % Of Sales - 16.67% 18.85% 7.22% 13.69% 6.13% 5.21% Miscellaneous Exp. - 0.12 0.16 0.07 0.16 0.18 0.41 % Of Sales - 0.07% 0.11% 0.05% 0.15% 0.19% 0.48% EBITDA 5.02 7.56 6.66 14.44 0.58 4.51 7.74 EBITDA Margin 2.53% 4.19% 4.76% 11.01% 0.54% 4.74% 9.04% Other Income 1.03 1.16 2.62 1.99 1.31 1.52 1.54 Interest 6.86 4.79 2.56 0.32 0.11 0.07 0.04 Depreciation 24.70 20.09 11.96 3.67 3.17 2.10 1.39 PBT -25.51 -16.16 -5.23 12.43 -1.39 3.86 7.86 Tax -1.28 -1.82 1.08 3.53 -0.16 1.12 2.31 Tax Rate 5.02% 11.26% -23.03% 28.40% 44.44% 29.02% 29.39% PAT -24.23 -14.35 -5.77 8.91 -0.21 2.74 5.55 PAT before Minority Interest -24.23 -14.35 -5.77 8.91 -0.21 2.74 5.55 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -12.23% -7.95% -4.12% 6.79% -0.20% 2.88% 6.48% PAT Growth 0.00% - - - - -50.63% EPS -8.84 -5.24 -2.11 3.25 -0.08 1.00 2.03

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 121.78 94.46 91.37 66.37 68.85 68.93 69.78 26.98 21.44 18.32 Share Capital 25.85 25.16 25.16 24.56 24.56 17.54 17.54 14.36 14.36 14.36 Total Reserves 95.93 69.30 66.21 41.81 44.29 51.39 52.23 12.62 7.08 3.96 Non-Current Liabilities 1.15 0.85 0.96 0.95 1.05 0.87 0.65 3.03 2.73 2.46 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.22 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.46 2.23 2.00 Long Term Provisions 1.18 0.94 1.03 0.94 0.87 0.76 0.49 0.45 0.34 0.00 Current Liabilities 50.33 29.24 32.88 18.20 18.59 19.82 21.37 23.79 19.88 19.60 Trade Payables 30.84 24.82 18.32 15.59 14.99 16.17 16.47 18.36 14.60 11.71 Other Current Liabilities 1.31 0.95 10.00 1.67 1.64 0.52 0.31 0.36 0.40 0.53 Short Term Borrowings 14.68 0.00 0.00 0.00 0.00 0.00 0.00 1.64 0.00 3.02 Short Term Provisions 3.50 3.47 4.56 0.94 1.96 3.12 4.59 3.44 4.88 4.33 Total Liabilities 173.26 124.55 125.21 85.52 88.49 89.62 91.80 53.80 44.05 40.38 Net Block 11.94 11.45 12.56 13.99 15.41 9.78 9.56 6.72 7.23 8.23 Gross Block 35.95 32.45 31.14 29.84 28.09 20.36 18.76 14.98 14.45 14.24 Accumulated Depreciation 24.01 21.00 18.58 15.85 12.68 10.59 9.19 8.26 7.23 6.01 Non Current Assets 44.26 36.75 50.01 24.39 29.73 27.24 36.05 9.33 8.56 8.42 Capital Work in Progress 4.80 3.10 0.00 0.04 0.00 1.55 0.04 2.50 1.13 0.00 Non Current Investment 6.77 9.54 34.84 9.99 14.03 15.62 26.15 0.00 0.09 0.08 Long Term Loans & Adv. 20.75 12.67 2.61 0.37 0.29 0.29 0.31 0.11 0.11 0.11 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 128.99 87.80 75.21 61.13 58.76 62.37 55.74 44.48 35.50 31.96 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 40.06 35.83 27.98 28.13 25.34 32.51 24.28 23.91 16.33 17.62 Sundry Debtors 73.71 43.56 38.32 28.84 29.14 22.10 22.93 17.08 15.78 11.69 Cash & Bank 0.14 0.88 2.20 1.33 0.73 1.69 2.46 0.14 0.76 0.16 Other Current Assets 15.08 0.97 0.04 0.64 3.55 6.07 6.07 3.35 2.63 2.49 Short Term Loans & Adv. 13.99 6.56 6.67 2.20 3.27 3.54 5.63 3.08 2.60 2.39 Net Current Assets 78.67 58.56 42.33 42.94 40.17 42.56 34.37 20.69 15.61 12.36 Total Assets 173.25 124.55 125.22 85.52 88.49 89.61 91.79 53.81 44.06 40.38

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 89.98 80.36 89.63 66.30 68.83 68.93 Share Capital 25.85 25.16 25.16 24.56 24.56 17.54 Total Reserves 64.13 55.20 64.47 41.74 44.27 51.38 Non-Current Liabilities 60.26 36.12 13.35 0.95 1.05 0.87 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.50 0.98 1.04 0.94 0.87 0.76 Current Liabilities 73.68 40.52 35.96 18.23 18.60 19.81 Trade Payables 33.61 26.46 18.70 15.60 14.99 16.17 Other Current Liabilities 19.06 10.32 12.63 1.67 1.64 0.52 Short Term Borrowings 14.68 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 6.34 3.74 4.63 0.96 1.96 3.13 Total Liabilities 223.92 157.00 138.94 85.48 88.48 89.61 Net Block 102.70 62.08 29.10 14.08 15.41 9.78 Gross Block 145.79 85.08 47.91 29.93 28.09 20.36 Accumulated Depreciation 43.09 23.00 18.81 15.85 12.68 10.59 Non Current Assets 112.31 72.82 62.03 24.27 29.61 27.23 Capital Work in Progress 4.80 3.10 0.00 0.04 0.00 1.55 Non Current Investment 4.70 7.53 32.84 9.89 13.92 15.61 Long Term Loans & Adv. 0.11 0.11 0.09 0.27 0.28 0.29 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 111.62 84.17 76.90 61.21 58.86 62.37 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 53.77 41.79 28.95 28.18 25.34 32.51 Sundry Debtors 27.24 27.83 36.37 28.77 29.14 22.10 Cash & Bank 1.00 1.12 2.30 1.35 0.83 1.69 Other Current Assets 29.61 2.76 0.94 0.66 3.55 6.07 Short Term Loans & Adv. 21.84 10.68 8.35 2.25 3.27 3.54 Net Current Assets 37.93 43.65 40.94 42.98 40.27 42.56 Total Assets 223.93 156.99 138.93 85.48 88.47 89.60

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -30.14 -10.29 13.66 -0.84 5.55 -3.24 -4.43 3.35 4.56 4.65 PBT 4.91 8.62 14.19 -0.32 3.88 7.86 11.34 8.36 7.72 6.34 Adjustment 1.54 0.51 1.46 1.45 1.06 0.01 -0.41 1.71 1.85 2.12 Changes in Working Capital -35.08 -17.29 1.75 -1.91 1.71 -8.78 -11.32 -3.85 -2.32 -1.60 Cash after chg. in Working capital -28.63 -8.15 17.40 -0.78 6.65 -0.92 -0.39 6.22 7.25 6.86 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.52 -2.14 -3.73 -0.06 -1.10 -2.32 -4.04 -2.87 -2.69 -2.21 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -8.67 12.76 -27.06 3.91 -3.54 8.83 -26.19 -1.81 -1.35 -0.70 Net Fixed Assets -5.20 -4.41 -1.26 -1.79 -6.18 -3.11 -1.32 -1.90 -1.34 -0.71 Net Investments 2.77 25.30 -24.85 4.04 1.59 10.53 -26.15 0.09 -0.01 0.00 Others -6.24 -8.13 -0.95 1.66 1.05 1.41 1.28 0.00 0.00 0.01 Cash from Financing Activity 38.08 -3.79 14.27 -2.47 -2.97 -6.35 32.94 -2.16 -2.62 -3.93 Net Cash Inflow / Outflow -0.73 -1.32 0.87 0.60 -0.97 -0.77 2.33 -0.62 0.59 0.02 Opening Cash & Equivalents 0.88 2.20 1.33 0.73 1.69 2.46 0.14 0.76 0.16 0.14 Closing Cash & Equivalent 0.14 0.88 2.20 1.33 0.73 1.69 2.46 0.14 0.76 0.16

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity -5.98 -2.01 13.33 -0.89 5.56 -3.25 PBT -16.16 -4.69 12.43 -0.37 3.86 7.86 Adjustment 23.69 13.12 2.66 1.45 1.06 0.01 Changes in Working Capital -11.98 -8.29 1.97 -1.91 1.73 -8.79 Cash after chg. in Working capital -4.45 0.13 17.07 -0.83 6.65 -0.93 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.53 -2.14 -3.73 -0.06 -1.10 -2.32 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -12.90 14.70 -26.65 3.82 -3.54 8.83 Net Fixed Assets -5.20 -4.41 -1.26 -1.79 -6.18 Net Investments 2.77 25.30 -24.85 4.04 1.59 Others -10.47 -6.19 -0.54 1.57 1.05 Cash from Financing Activity 18.78 -13.88 14.27 -2.42 -2.87 -6.35 Net Cash Inflow / Outflow -0.11 -1.18 0.95 0.51 -0.86 -0.77 Opening Cash & Equivalents 1.12 2.30 1.35 0.83 1.69 2.46 Closing Cash & Equivalent 1.00 1.12 2.30 1.35 0.83 1.69

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 47.11 37.54 36.32 27.02 28.03 28.06 28.41 13.42 10.66 9.11 ROA 2.27% 5.28% 10.04% -0.19% 3.10% 6.12% 9.98% 11.32% 12.10% 11.34% ROE 3.13% 7.10% 13.41% -0.24% 4.01% 8.01% 15.02% 22.89% 25.70% 25.00% ROCE 4.57% 9.35% 18.09% -0.30% 5.73% 11.39% 22.73% 33.04% 35.60% 31.71% Fixed Asset Turnover 4.87 4.35 4.31 3.69 3.93 4.38 4.62 4.86 4.51 4.07 Receivable days 128.48 108.00 93.18 99.04 98.30 95.96 93.80 83.78 77.44 72.30 Inventory Days 83.15 84.17 77.85 91.33 111.01 121.05 112.98 102.60 95.73 97.45 Payable days 97.26 89.20 70.68 76.08 85.76 73.03 99.18 89.74 90.17 75.55 Cash Conversion Cycle 114.37 102.96 100.35 114.29 123.55 143.97 107.60 96.63 83.00 94.20 Total Debt/Equity 0.12 0.00 0.00 0.00 0.00 0.00 0.00 0.15 0.10 0.29 Interest Cover 14.45 137.22 194.87 -1.88 57.15 214.57 94.67 13.25 12.30 10.54

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 34.81 31.94 35.62 26.99 28.02 28.06 ROA -7.53% -3.90% 7.94% -0.24% 3.08% 6.19% ROE -16.85% -6.79% 11.43% -0.31% 3.98% 8.05% ROCE -12.30% -2.50% 16.36% -0.38% 5.71% 11.45% Fixed Asset Turnover 1.56 2.10 3.37 3.68 3.93 4.21 Receivable days 55.69 83.71 90.61 98.96 98.30 94.19 Inventory Days 96.62 92.24 79.46 91.46 111.01 138.59 Payable days 113.36 98.97 72.26 76.17 85.77 72.36 Cash Conversion Cycle 38.95 76.98 97.82 114.25 123.54 160.41 Total Debt/Equity 0.16 0.00 0.00 0.00 0.00 0.00 Interest Cover -2.38 -0.83 39.77 -2.33 56.64 214.47

Top Investors:

asha mukul agrawal

jainam broking limited

Annual Reports:

News Update:

Zota Health Care gets registration licenses for two products in Myanmar
4th Sep 2024, 14:41 PM

The company shall commence export of these products in Myanmar
Read More
Zota Health Care - Quarterly Results
14th Aug 2024, 12:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback